Released on = September 14, 2006, 6:18 am

Press Release Author = Gentris Corporation

Industry = Pharmaceuticals

Press Release Summary = Gentris Corporation (Gentris), a leading global provider of
applied clinical pharmacogenomic services and diagnostic product solutions, today
announced the promotion of Karen Nield to VP, Finance and Human Resources.

Press Release Body = Research Triangle Park, North Carolina - September 14th 2006 -
Gentris Corporation (Gentris), a leading global provider of applied clinical
pharmacogenomic services and diagnostic product solutions, today announced the
promotion of Karen Nield to VP, Finance and Human Resources. Prior to this
promotion Nield held the position of Executive Director, Finance.

As VP, Finance and Human Resources Nield will play a pivotal role in contributing to
Gentris' continued growth. She will lead Gentris in standardizing human resources
policies, attracting top talent and strengthening employee benefits. As Executive
Director, Finance, Nield was instrumental in the success of Gentris' most recent
round of funding.

"Early on Karen took on VP-level responsibilities for both Finance and Accounting to
support Gentris' CGS and Diagnostics divisions," commented Gentris President and CEO
Michael Murphy. "In addition, Karen has taken on the task of heading up Human
Resources where she has done an incredible job. We expect the best of those who
work at Gentris and Karen is a prime example of someone who has surpassed all
expectations."

Nield is a CPA with more than 13 years of broad range public and private industry
accounting experience with specialties in financial forecasting and maintaining
compliance of state laws and reporting standards. Prior to joining Gentris in 2004,
Nield worked internationally in the Transaction Services Mergers and Acquisitions
division of PriceWaterhouse Coopers. She holds dual BS degrees in Accounting and
Marketing from the University of North Carolina.

This announcement comes shortly after Gentris finalized an exclusive ten-year
licensing agreement with FALCO biosystems Ltd., one of the largest publicly-traded
medical testing laboratories in Japan. The agreement marks the establishment of
Japan's first Good Laboratory Practice (GLP)-compliant pharmacogenomics laboratory,
moving Japan into the era of personalized medicine.

###

About Gentris Corporation
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic
services and diagnostic product solutions. As pioneers in the field of
pharmacogenomics, Gentris helps pharmaceutical companies and clinical research
organizations effectively integrate pharmacogenomics into their drug development
programs to deliver safer, more effective compounds to the market sooner. Gentris is
developing validated reference controls and diagnostic test kits that will bring the
promise of personalized medicine to physicians and patients, which will enhance
patient management, improve patients\' response to therapy and revolutionize medicine
through pharmacogenomics. For additional information, please visit
http://www.gentris.com



Web Site = http://www.gentris.com

Contact Details = Jonathan Jordan
919 Marketing/919-557-7890
press@gentris.com